Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVE1642 with Sorafenib or Erlotinib in Advanced Liver Carcinoma
NCT00791544Phase 2Terminated
- Sponsor
- Sanofi
- Start
- Nov 2008
- Primary completion
- Nov 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of EM164 in hepatocellular carcinoma (HCC), sponsored by Sanofi. Started Nov 2008; status: terminated.
02
Drugs
EM164
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00791544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00791544.